What we do
Our approach
Pipeline
Technology
Patient Stories
About us
Management
Board
Clinical Advisory Board
Careers
Newsroom
Investors
Press releases
What we do
Our approach
Pipeline
Technology
Patient Stories
About us
Management
Board
Clinical Advisory Board
Careers
Newsroom
Investors
Press releases
Overview
Press releases
Events
Corporate Governance
Shareholder & stock info
Financial reports
Financial calendar
Transactions
Back
Back
Mendus to present preclinical data supporting the combination potential of ilixadencel with the immune checkpoint inhibitor avelumab at SITC 2024
8:00:00 AM
Keep reading
Mendus AB Interim Report January – September 2024
Read
